Submit your business proposal
English
企業情報
戦略
チーム
ファンド
投資先企業
ニュース
お問い合わせ
ビジネス提案書の提出はこちら
English
企業情報
戦略
チーム
ファンド
投資先企業
ニュース
お問い合わせ
ニュース
News type
記事
イベント
プレスリリース
地域
日本
EU
最新ニュース
15th 3月 2024
Acticor Biotech completes a capital increase for a total gross amount of 8 million euros
Read more
26th 1月 2024
Sequana Medical announces DSMB approval to start randomized MOJAVE cohort – US Phase 1/2a study of DSR® 2.0 for treatment of heart failure
Read more
26th 1月 2024
PRISM BioLab raises 1.5 billion yen in Series C fundraising to advance technologies and programs targeting protein-protein interactions
Read more
4th 1月 2024
Sequana Medical granted US CPT® III reimbursement codes for alfapump® system
Read more
30th 11月 2023
Sequana Medical announces positive data from non-randomized cohort in US Phase 1/2a MOJAVE study of DSR® 2.0 for treatment of heart failure
Read more
30th 11月 2023
Acticor Biotech completes a capital increase for a total gross amount of approximately 2.6 million euros, via the issuance of 850,360 shares
Read more
29th 11月 2023
PRISM BioLab and Lilly Enter into a Drug Discovery Collaboration on a Protein-Protein Interaction Target
Read more
19th 10月 2023
Sequana Medical announces additional alfapump data supporting strong and durable clinical profile; PMA on track for year-end submission
Read more
19th 10月 2023
Sequana Medical announces initial positive data from MOJAVE, a US Phase 1/2a study of DSR® 2.0 for treatment of heart failure through breaking vicious cycle of cardiorenal syndrome
Read more
1
2
3
Sign up
You are added to the list, thank you!